SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-15-000929
Filing Date
2015-03-12
Accepted
2015-03-12 16:20:58
Documents
10
Period of Report
2015-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pphm_10q-013115.htm 10-Q 540979
2 CERTIFICATION pphm_10q-ex3101.htm EX-31.1 7674
3 CERTIFICATION pphm_10q-ex3102.htm EX-31.2 7775
4 CERTIFICATION pphm_10q-ex3200.htm EX-32 5799
  Complete submission text file 0001019687-15-000929.txt   3728394

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pphm-20150131.xml EX-101.INS 502085
6 XBRL SCHEMA FILE pphm-20150131.xsd EX-101.SCH 26963
7 XBRL CALCULATION FILE pphm-20150131_cal.xml EX-101.CAL 54407
8 XBRL DEFINITION FILE pphm-20150131_def.xml EX-101.DEF 90564
9 XBRL LABEL FILE pphm-20150131_lab.xml EX-101.LAB 217202
10 XBRL PRESENTATION FILE pphm-20150131_pre.xml EX-101.PRE 180044
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 15696172
SIC: 2834 Pharmaceutical Preparations